NCT05081440View on ClinicalTrials.gov

A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center

UnknownOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions
Lipoprotein Disorder
Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Huashan Hospital

OTHER

NCT05081440 - A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center | Biotech Hunter | Biotech Hunter